Medilink-Global UK Limited Statement re. Suspension (5892Q)
18 June 2015 - 11:00PM
UK Regulatory
TIDMMEDI
RNS Number : 5892Q
Medilink-Global UK Limited
18 June 2015
MEDILINK-GLOBAL UK LIMITED
("Medilink", the "Company" or the "Group")
Statement re. suspension of trading of the Company's shares
The Directors of Medilink announce that it has become apparent
that the Company will not be in a position to publish its audited
report and accounts for the year ended 31 December 2014 by 30 June
2015 in accordance with the AIM Rules for Companies. As a result,
the Company's shares have been suspended from trading on AIM
pursuant to AIM Rule 19. The suspension, which commenced at 2:00pm
today, will remain in place until the Company's accounts have been
published and posted to shareholders. The inability to finalise the
accounts prior to the 30 June 2015 is due to an unanticipated delay
in the audit process.
A further announcement will be made in due course.
For further information contact:
MediLink-Global UK Limited Tel: + 603 2296 3113
Shia Kok Fat, Chief Executive
Officer
www.medilink-global.com
Allenby Capital Limited Tel: +44 (0)20 3328 5656
(Nominated Adviser and Broker)
Nick Athanas, James Reeve
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSPKFDQBBKDBAD
Medilink (LSE:MEDI)
Historical Stock Chart
From May 2024 to Jun 2024
Medilink (LSE:MEDI)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Medilink (London Stock Exchange): 0 recent articles
More Medilink News Articles